DENTSPLY SIRONA Inc header image

DENTSPLY SIRONA Inc

XRAY

Equity

ISIN null / Valor 31773200

NASDAQ (2026-10-07)
USD 8.54+0.23%

DENTSPLY SIRONA Inc
UMushroom community rating:

star star star star star
4.00 1 votes No rating yet
NegativeNeutralPositive

About company

DENTSPLY SIRONA Inc is a global leader in the manufacturing of professional dental products and technologies, working in collaboration with partners to develop innovative solutions for dental professionals worldwide. With a mission to transform dentistry and improve oral health on a global scale, the company is dedicated to empowering dental practices, clinics, laboratories, and distributors to deliver top-quality dental care to patients. DENTSPLY SIRONA's research division plays a key role in driving the development of next-generation dental solutions, reflecting the company's commitment to advancing the field of dentistry.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-30.7%1Y
-73.7%3Y
-85.3%5Y

Performance

47.4%1Y
43.9%3Y
39.7%5Y

Volatility

Market cap

1702 M

Market cap (USD)

Daily traded volume (Shares)

4,221,269

Daily traded volume (Shares)

1 day high/low

18.86 / 18.36

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

1 votes
Performance:
starstarstarstarstar
2.00
Innovation:
starstarstarstarstar
4.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
3.00
Matthew Tombaugh
Switzerland, 23 Mar 2026
star star star star star
A textbook deep value play. The stock is priced for failure at 8.9x earnings, but management is at the 10-yard line of a turnaround. Cutting the dividend to buy back shares at these depressed levels is a aggressive, shareholder-friendly move.

EQUITIES OF THE SAME SECTOR

Stryker Corp
Stryker Corp Stryker Corp Valor: 974330
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.84%USD 275.85
BACHEM HOLDING LTD
BACHEM HOLDING LTD BACHEM HOLDING LTD Valor: 117649372
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.37%CHF 80.45
Herbalife Ltd
Herbalife Ltd Herbalife Ltd Valor: 2002103
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.56%USD 12.65
Estee Lauder Companies Inc
Estee Lauder Companies Inc Estee Lauder Companies Inc Valor: 99350
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.17%USD 94.45
Humana Inc
Humana Inc Humana Inc Valor: 940174
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.92%USD 396.51
Boston Scientific Corp
Boston Scientific Corp Boston Scientific Corp Valor: 913577
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.45%USD 41.58
H. Lundbeck A/S
H. Lundbeck A/S H. Lundbeck A/S Valor: 119252584
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.58%DKK 43.45
Alcon Inc.
Alcon Inc. Alcon Inc. Valor: 43249246
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.48%CHF 51.90
Icon PLC
Icon PLC Icon PLC Valor: 1017575
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.48%USD 164.08
Royalty Pharma PLC
Royalty Pharma PLC Royalty Pharma PLC Valor: 55041695
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.57%USD 56.76